Global Biosimilar of Remicade Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Biosimilar of Remicade Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  • 1.2.2 Monoclonal Antibodies
  • 1.2.3 Interferon
  • 1.2.4 Erythropoietin
  • 1.2.5 Insulin
  • 1.2.6 Vaccines
  • 1.2.7 Other
• 1.3 Market by Application
  • 1.3.1 Global Biosimilar of Remicade Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Tumor
  • 1.3.3 Diabetes
  • 1.3.4 Cardiovascular
  • 1.3.5 Hemophilia
  • 1.3.6 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Biosimilar of Remicade Market Perspective (2018-2029)
• 2.2 Global Biosimilar of Remicade Growth Trends by Region
  • 2.2.1 Biosimilar of Remicade Market Size by Region: 2018 VS 2022 VS 2029
  • 2.2.2 Biosimilar of Remicade Historic Market Size by Region (2018-2023)
  • 2.2.3 Biosimilar of Remicade Forecasted Market Size by Region (2024-2029)
• 2.3 Biosimilar of Remicade Market Dynamics
  • 2.3.1 Biosimilar of Remicade Industry Trends
  • 2.3.2 Biosimilar of Remicade Market Drivers
  • 2.3.3 Biosimilar of Remicade Market Challenges
  • 2.3.4 Biosimilar of Remicade Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Biosimilar of Remicade by Players
  • 3.1.1 Global Biosimilar of Remicade Revenue by Players (2018-2023)
  • 3.1.2 Global Biosimilar of Remicade Revenue Market Share by Players (2018-2023)
• 3.2 Global Biosimilar of Remicade Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Biosimilar of Remicade, Ranking by Revenue, 2021 VS 2022 VS 2023
• 3.4 Global Biosimilar of Remicade Market Concentration Ratio
  • 3.4.1 Global Biosimilar of Remicade Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Biosimilar of Remicade Revenue in 2022
• 3.5 Global Key Players of Biosimilar of Remicade Head office and Area Served
• 3.6 Global Key Players of Biosimilar of Remicade, Product and Application
• 3.7 Global Key Players of Biosimilar of Remicade, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Biosimilar of Remicade Breakdown Data by Type

• 4.1 Global Biosimilar of Remicade Historic Market Size by Type (2018-2023)
• 4.2 Global Biosimilar of Remicade Forecasted Market Size by Type (2024-2029)

5 Biosimilar of Remicade Breakdown Data by Application

• 5.1 Global Biosimilar of Remicade Historic Market Size by Application (2018-2023)
• 5.2 Global Biosimilar of Remicade Forecasted Market Size by Application (2024-2029)

6 North America

• 6.1 North America Biosimilar of Remicade Market Size (2018-2029)
• 6.2 North America Biosimilar of Remicade Market Size by Type
  • 6.2.1 North America Biosimilar of Remicade Market Size by Type (2018-2023)
  • 6.2.2 North America Biosimilar of Remicade Market Size by Type (2024-2029)
  • 6.2.3 North America Biosimilar of Remicade Market Share by Type (2018-2029)
• 6.3 North America Biosimilar of Remicade Market Size by Application
  • 6.3.1 North America Biosimilar of Remicade Market Size by Application (2018-2023)
  • 6.3.2 North America Biosimilar of Remicade Market Size by Application (2024-2029)
  • 6.3.3 North America Biosimilar of Remicade Market Share by Application (2018-2029)
• 6.4 North America Biosimilar of Remicade Market Size by Country
  • 6.4.1 North America Biosimilar of Remicade Market Size by Country: 2018 VS 2022 VS 2029
  • 6.4.2 North America Biosimilar of Remicade Market Size by Country (2018-2023)
  • 6.4.3 North America Biosimilar of Remicade Market Size by Country (2024-2029)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe Biosimilar of Remicade Market Size (2018-2029)
• 7.2 Europe Biosimilar of Remicade Market Size by Type
  • 7.2.1 Europe Biosimilar of Remicade Market Size by Type (2018-2023)
  • 7.2.2 Europe Biosimilar of Remicade Market Size by Type (2024-2029)
  • 7.2.3 Europe Biosimilar of Remicade Market Share by Type (2018-2029)
• 7.3 Europe Biosimilar of Remicade Market Size by Application
  • 7.3.1 Europe Biosimilar of Remicade Market Size by Application (2018-2023)
  • 7.3.2 Europe Biosimilar of Remicade Market Size by Application (2024-2029)
  • 7.3.3 Europe Biosimilar of Remicade Market Share by Application (2018-2029)
• 7.4 Europe Biosimilar of Remicade Market Size by Country
  • 7.4.1 Europe Biosimilar of Remicade Market Size by Country: 2018 VS 2022 VS 2029
  • 7.4.2 Europe Biosimilar of Remicade Market Size by Country (2018-2023)
  • 7.4.3 Europe Biosimilar of Remicade Market Size by Country (2024-2029)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 China

• 8.1 China Biosimilar of Remicade Market Size (2018-2029)
• 8.2 China Biosimilar of Remicade Market Size by Type
  • 8.2.1 China Biosimilar of Remicade Market Size by Type (2018-2023)
  • 8.2.2 China Biosimilar of Remicade Market Size by Type (2024-2029)
  • 8.2.3 China Biosimilar of Remicade Market Share by Type (2018-2029)
• 8.3 China Biosimilar of Remicade Market Size by Application
  • 8.3.1 China Biosimilar of Remicade Market Size by Application (2018-2023)
  • 8.3.2 China Biosimilar of Remicade Market Size by Application (2024-2029)
  • 8.3.3 China Biosimilar of Remicade Market Share by Application (2018-2029)

9 Asia (excluding China)

• 9.1 Asia Biosimilar of Remicade Market Size (2018-2029)
• 9.2 Asia Biosimilar of Remicade Market Size by Type
  • 9.2.1 Asia Biosimilar of Remicade Market Size by Type (2018-2023)
  • 9.2.2 Asia Biosimilar of Remicade Market Size by Type (2024-2029)
  • 9.2.3 Asia Biosimilar of Remicade Market Share by Type (2018-2029)
• 9.3 Asia Biosimilar of Remicade Market Size by Application
  • 9.3.1 Asia Biosimilar of Remicade Market Size by Application (2018-2023)
  • 9.3.2 Asia Biosimilar of Remicade Market Size by Application (2024-2029)
  • 9.3.3 Asia Biosimilar of Remicade Market Share by Application (2018-2029)
• 9.4 Asia Biosimilar of Remicade Market Size by Region
  • 9.4.1 Asia Biosimilar of Remicade Market Size by Region: 2018 VS 2022 VS 2029
  • 9.4.2 Asia Biosimilar of Remicade Market Size by Region (2018-2023)
  • 9.4.3 Asia Biosimilar of Remicade Market Size by Region (2024-2029)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size (2018-2029)
• 10.2 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Type (2018-2023)
  • 10.2.2 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Type (2024-2029)
  • 10.2.3 Middle East, Africa, and Latin America Biosimilar of Remicade Market Share by Type (2018-2029)
• 10.3 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Application (2018-2023)
  • 10.3.2 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Application (2024-2029)
  • 10.3.3 Middle East, Africa, and Latin America Biosimilar of Remicade Market Share by Application (2018-2029)
• 10.4 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Country: 2018 VS 2022 VS 2029
  • 10.4.2 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Country (2018-2023)
  • 10.4.3 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Country (2024-2029)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 Roche
  • 11.1.1 Roche Company Details
  • 11.1.2 Roche Business Overview
  • 11.1.3 Roche Biosimilar of Remicade Introduction
  • 11.1.4 Roche Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.1.5 Roche Recent Developments
• 11.2 Amgen
  • 11.2.1 Amgen Company Details
  • 11.2.2 Amgen Business Overview
  • 11.2.3 Amgen Biosimilar of Remicade Introduction
  • 11.2.4 Amgen Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.2.5 Amgen Recent Developments
• 11.3 AbbVie
  • 11.3.1 AbbVie Company Details
  • 11.3.2 AbbVie Business Overview
  • 11.3.3 AbbVie Biosimilar of Remicade Introduction
  • 11.3.4 AbbVie Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.3.5 AbbVie Recent Developments
• 11.4 Sanofi-Aventis
  • 11.4.1 Sanofi-Aventis Company Details
  • 11.4.2 Sanofi-Aventis Business Overview
  • 11.4.3 Sanofi-Aventis Biosimilar of Remicade Introduction
  • 11.4.4 Sanofi-Aventis Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.4.5 Sanofi-Aventis Recent Developments
• 11.5 Johnson & Johnson
  • 11.5.1 Johnson & Johnson Company Details
  • 11.5.2 Johnson & Johnson Business Overview
  • 11.5.3 Johnson & Johnson Biosimilar of Remicade Introduction
  • 11.5.4 Johnson & Johnson Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.5.5 Johnson & Johnson Recent Developments
• 11.6 Pfizer
  • 11.6.1 Pfizer Company Details
  • 11.6.2 Pfizer Business Overview
  • 11.6.3 Pfizer Biosimilar of Remicade Introduction
  • 11.6.4 Pfizer Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.6.5 Pfizer Recent Developments
• 11.7 Novo Nordisk
  • 11.7.1 Novo Nordisk Company Details
  • 11.7.2 Novo Nordisk Business Overview
  • 11.7.3 Novo Nordisk Biosimilar of Remicade Introduction
  • 11.7.4 Novo Nordisk Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.7.5 Novo Nordisk Recent Developments
• 11.8 Eli Lilly
  • 11.8.1 Eli Lilly Company Details
  • 11.8.2 Eli Lilly Business Overview
  • 11.8.3 Eli Lilly Biosimilar of Remicade Introduction
  • 11.8.4 Eli Lilly Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.8.5 Eli Lilly Recent Developments
• 11.9 Novartis
  • 11.9.1 Novartis Company Details
  • 11.9.2 Novartis Business Overview
  • 11.9.3 Novartis Biosimilar of Remicade Introduction
  • 11.9.4 Novartis Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.9.5 Novartis Recent Developments
• 11.10 Merck
  • 11.10.1 Merck Company Details
  • 11.10.2 Merck Business Overview
  • 11.10.3 Merck Biosimilar of Remicade Introduction
  • 11.10.4 Merck Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.10.5 Merck Recent Developments
• 11.11 3sbio
  • 11.11.1 3sbio Company Details
  • 11.11.2 3sbio Business Overview
  • 11.11.3 3sbio Biosimilar of Remicade Introduction
  • 11.11.4 3sbio Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.11.5 3sbio Recent Developments
• 11.12 Changchun High Tech
  • 11.12.1 Changchun High Tech Company Details
  • 11.12.2 Changchun High Tech Business Overview
  • 11.12.3 Changchun High Tech Biosimilar of Remicade Introduction
  • 11.12.4 Changchun High Tech Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.12.5 Changchun High Tech Recent Developments
• 11.13 CP Guojian
  • 11.13.1 CP Guojian Company Details
  • 11.13.2 CP Guojian Business Overview
  • 11.13.3 CP Guojian Biosimilar of Remicade Introduction
  • 11.13.4 CP Guojian Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.13.5 CP Guojian Recent Developments
• 11.14 Biotech
  • 11.14.1 Biotech Company Details
  • 11.14.2 Biotech Business Overview
  • 11.14.3 Biotech Biosimilar of Remicade Introduction
  • 11.14.4 Biotech Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.14.5 Biotech Recent Developments
• 11.15 Gelgen
  • 11.15.1 Gelgen Company Details
  • 11.15.2 Gelgen Business Overview
  • 11.15.3 Gelgen Biosimilar of Remicade Introduction
  • 11.15.4 Gelgen Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.15.5 Gelgen Recent Developments
• 11.16 Innovent
  • 11.16.1 Innovent Company Details
  • 11.16.2 Innovent Business Overview
  • 11.16.3 Innovent Biosimilar of Remicade Introduction
  • 11.16.4 Innovent Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.16.5 Innovent Recent Developments
• 11.17 Dong Bao
  • 11.17.1 Dong Bao Company Details
  • 11.17.2 Dong Bao Business Overview
  • 11.17.3 Dong Bao Biosimilar of Remicade Introduction
  • 11.17.4 Dong Bao Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.17.5 Dong Bao Recent Developments
• 11.18 Ganlee
  • 11.18.1 Ganlee Company Details
  • 11.18.2 Ganlee Business Overview
  • 11.18.3 Ganlee Biosimilar of Remicade Introduction
  • 11.18.4 Ganlee Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.18.5 Ganlee Recent Developments
• 11.19 United Laboratories
  • 11.19.1 United Laboratories Company Details
  • 11.19.2 United Laboratories Business Overview
  • 11.19.3 United Laboratories Biosimilar of Remicade Introduction
  • 11.19.4 United Laboratories Revenue in Biosimilar of Remicade Business (2018-2023)
  • 11.19.5 United Laboratories Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer
• 13.3 Author Details

List of Tables

• Table 1. Global Biosimilar of Remicade Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
• Table 2. Key Players of Monoclonal Antibodies
• Table 3. Key Players of Interferon
• Table 4. Key Players of Erythropoietin
• Table 5. Key Players of Insulin
• Table 6. Key Players of Vaccines
• Table 7. Key Players of Other
• Table 8. Global Biosimilar of Remicade Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
• Table 9. Global Biosimilar of Remicade Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
• Table 10. Global Biosimilar of Remicade Market Size by Region (2018-2023) & (US$ Million)
• Table 11. Global Biosimilar of Remicade Market Share by Region (2018-2023)
• Table 12. Global Biosimilar of Remicade Forecasted Market Size by Region (2024-2029) & (US$ Million)
• Table 13. Global Biosimilar of Remicade Market Share by Region (2024-2029)
• Table 14. Biosimilar of Remicade Market Trends
• Table 15. Biosimilar of Remicade Market Drivers
• Table 16. Biosimilar of Remicade Market Challenges
• Table 17. Biosimilar of Remicade Market Restraints
• Table 18. Global Biosimilar of Remicade Revenue by Players (2018-2023) & (US$ Million)
• Table 19. Global Biosimilar of Remicade Revenue Share by Players (2018-2023)
• Table 20. Global Top Biosimilar of Remicade by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar of Remicade as of 2022)
• Table 21. Global Biosimilar of Remicade Industry Ranking 2021 VS 2022 VS 2023
• Table 22. Global 5 Largest Players Market Share by Biosimilar of Remicade Revenue (CR5 and HHI) & (2018-2023)
• Table 23. Global Key Players of Biosimilar of Remicade, Headquarters and Area Served
• Table 24. Global Key Players of Biosimilar of Remicade, Product and Application
• Table 25. Global Key Players of Biosimilar of Remicade, Product and Application
• Table 26. Mergers & Acquisitions, Expansion Plans
• Table 27. Global Biosimilar of Remicade Market Size by Type (2018-2023) & (US$ Million)
• Table 28. Global Biosimilar of Remicade Revenue Market Share by Type (2018-2023)
• Table 29. Global Biosimilar of Remicade Forecasted Market Size by Type (2024-2029) & (US$ Million)
• Table 30. Global Biosimilar of Remicade Revenue Market Share by Type (2024-2029)
• Table 31. Global Biosimilar of Remicade Market Size by Application (2018-2023) & (US$ Million)
• Table 32. Global Biosimilar of Remicade Revenue Share by Application (2018-2023)
• Table 33. Global Biosimilar of Remicade Forecasted Market Size by Application (2024-2029) & (US$ Million)
• Table 34. Global Biosimilar of Remicade Revenue Share by Application (2024-2029)
• Table 35. North America Biosimilar of Remicade Market Size by Type (2018-2023) & (US$ Million)
• Table 36. North America Biosimilar of Remicade Market Size by Type (2024-2029) & (US$ Million)
• Table 37. North America Biosimilar of Remicade Market Size by Application (2018-2023) & (US$ Million)
• Table 38. North America Biosimilar of Remicade Market Size by Application (2024-2029) & (US$ Million)
• Table 39. North America Biosimilar of Remicade Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
• Table 40. North America Biosimilar of Remicade Market Size by Country (2018-2023) & (US$ Million)
• Table 41. North America Biosimilar of Remicade Market Size by Country (2024-2029) & (US$ Million)
• Table 42. Europe Biosimilar of Remicade Market Size by Type (2018-2023) & (US$ Million)
• Table 43. Europe Biosimilar of Remicade Market Size by Type (2024-2029) & (US$ Million)
• Table 44. Europe Biosimilar of Remicade Market Size by Application (2018-2023) & (US$ Million)
• Table 45. Europe Biosimilar of Remicade Market Size by Application (2024-2029) & (US$ Million)
• Table 46. Europe Biosimilar of Remicade Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
• Table 47. Europe Biosimilar of Remicade Market Size by Country (2018-2023) & (US$ Million)
• Table 48. Europe Biosimilar of Remicade Market Size by Country (2024-2029) & (US$ Million)
• Table 49. China Biosimilar of Remicade Market Size by Type (2018-2023) & (US$ Million)
• Table 50. China Biosimilar of Remicade Market Size by Type (2024-2029) & (US$ Million)
• Table 51. China Biosimilar of Remicade Market Size by Application (2018-2023) & (US$ Million)
• Table 52. China Biosimilar of Remicade Market Size by Application (2024-2029) & (US$ Million)
• Table 53. Asia Biosimilar of Remicade Market Size by Type (2018-2023) & (US$ Million)
• Table 54. Asia Biosimilar of Remicade Market Size by Type (2024-2029) & (US$ Million)
• Table 55. Asia Biosimilar of Remicade Market Size by Application (2018-2023) & (US$ Million)
• Table 56. Asia Biosimilar of Remicade Market Size by Application (2024-2029) & (US$ Million)
• Table 57. Asia Biosimilar of Remicade Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
• Table 58. Asia Biosimilar of Remicade Market Size by Region (2018-2023) & (US$ Million)
• Table 59. Asia Biosimilar of Remicade Market Size by Region (2024-2029) & (US$ Million)
• Table 60. Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Type (2018-2023) & (US$ Million)
• Table 61. Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Type (2024-2029) & (US$ Million)
• Table 62. Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Application (2018-2023) & (US$ Million)
• Table 63. Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Application (2024-2029) & (US$ Million)
• Table 64. Middle East, Africa, and Latin America Biosimilar of Remicade Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
• Table 65. Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Country (2018-2023) & (US$ Million)
• Table 66. Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Country (2024-2029) & (US$ Million)
• Table 67. Roche Company Details
• Table 68. Roche Business Overview
• Table 69. Roche Biosimilar of Remicade Product
• Table 70. Roche Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 71. Roche Recent Developments
• Table 72. Amgen Company Details
• Table 73. Amgen Business Overview
• Table 74. Amgen Biosimilar of Remicade Product
• Table 75. Amgen Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 76. Amgen Recent Developments
• Table 77. AbbVie Company Details
• Table 78. AbbVie Business Overview
• Table 79. AbbVie Biosimilar of Remicade Product
• Table 80. AbbVie Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 81. AbbVie Recent Developments
• Table 82. Sanofi-Aventis Company Details
• Table 83. Sanofi-Aventis Business Overview
• Table 84. Sanofi-Aventis Biosimilar of Remicade Product
• Table 85. Sanofi-Aventis Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 86. Sanofi-Aventis Recent Developments
• Table 87. Johnson & Johnson Company Details
• Table 88. Johnson & Johnson Business Overview
• Table 89. Johnson & Johnson Biosimilar of Remicade Product
• Table 90. Johnson & Johnson Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 91. Johnson & Johnson Recent Developments
• Table 92. Pfizer Company Details
• Table 93. Pfizer Business Overview
• Table 94. Pfizer Biosimilar of Remicade Product
• Table 95. Pfizer Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 96. Pfizer Recent Developments
• Table 97. Novo Nordisk Company Details
• Table 98. Novo Nordisk Business Overview
• Table 99. Novo Nordisk Biosimilar of Remicade Product
• Table 100. Novo Nordisk Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 101. Novo Nordisk Recent Developments
• Table 102. Eli Lilly Company Details
• Table 103. Eli Lilly Business Overview
• Table 104. Eli Lilly Biosimilar of Remicade Product
• Table 105. Eli Lilly Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 106. Eli Lilly Recent Developments
• Table 107. Novartis Company Details
• Table 108. Novartis Business Overview
• Table 109. Novartis Biosimilar of Remicade Product
• Table 110. Novartis Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 111. Novartis Recent Developments
• Table 112. Merck Company Details
• Table 113. Merck Business Overview
• Table 114. Merck Biosimilar of Remicade Product
• Table 115. Merck Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 116. Merck Recent Developments
• Table 117. 3sbio Company Details
• Table 118. 3sbio Business Overview
• Table 119. 3sbio Biosimilar of Remicade Product
• Table 120. 3sbio Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 121. 3sbio Recent Developments
• Table 122. Changchun High Tech Company Details
• Table 123. Changchun High Tech Business Overview
• Table 124. Changchun High Tech Biosimilar of Remicade Product
• Table 125. Changchun High Tech Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 126. Changchun High Tech Recent Developments
• Table 127. CP Guojian Company Details
• Table 128. CP Guojian Business Overview
• Table 129. CP Guojian Biosimilar of Remicade Product
• Table 130. CP Guojian Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 131. CP Guojian Recent Developments
• Table 132. Biotech Company Details
• Table 133. Biotech Business Overview
• Table 134. Biotech Biosimilar of Remicade Product
• Table 135. Biotech Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 136. Biotech Recent Developments
• Table 137. Gelgen Company Details
• Table 138. Gelgen Business Overview
• Table 139. Gelgen Biosimilar of Remicade Product
• Table 140. Gelgen Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 141. Gelgen Recent Developments
• Table 142. Innovent Company Details
• Table 143. Innovent Business Overview
• Table 144. Innovent Biosimilar of Remicade Product
• Table 145. Innovent Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 146. Innovent Recent Developments
• Table 147. Dong Bao Company Details
• Table 148. Dong Bao Business Overview
• Table 149. Dong Bao Biosimilar of Remicade Product
• Table 150. Dong Bao Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 151. Dong Bao Recent Developments
• Table 152. Ganlee Company Details
• Table 153. Ganlee Business Overview
• Table 154. Ganlee Biosimilar of Remicade Product
• Table 155. Ganlee Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 156. Ganlee Recent Developments
• Table 157. United Laboratories Company Details
• Table 158. United Laboratories Business Overview
• Table 159. United Laboratories Biosimilar of Remicade Product
• Table 160. United Laboratories Revenue in Biosimilar of Remicade Business (2018-2023) & (US$ Million)
• Table 161. United Laboratories Recent Developments
• Table 162. Research Programs/Design for This Report
• Table 163. Key Data Information from Secondary Sources
• Table 164. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Biosimilar of Remicade Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 2. Global Biosimilar of Remicade Market Share by Type: 2022 VS 2029
• Figure 3. Monoclonal Antibodies Features
• Figure 4. Interferon Features
• Figure 5. Erythropoietin Features
• Figure 6. Insulin Features
• Figure 7. Vaccines Features
• Figure 8. Other Features
• Figure 9. Global Biosimilar of Remicade Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 10. Global Biosimilar of Remicade Market Share by Application: 2022 VS 2029
• Figure 11. Tumor Case Studies
• Figure 12. Diabetes Case Studies
• Figure 13. Cardiovascular Case Studies
• Figure 14. Hemophilia Case Studies
• Figure 15. Other Case Studies
• Figure 16. Biosimilar of Remicade Report Years Considered
• Figure 17. Global Biosimilar of Remicade Market Size (US$ Million), Year-over-Year: 2018-2029
• Figure 18. Global Biosimilar of Remicade Market Size, (US$ Million), 2018 VS 2022 VS 2029
• Figure 19. Global Biosimilar of Remicade Market Share by Region: 2022 VS 2029
• Figure 20. Global Biosimilar of Remicade Market Share by Players in 2022
• Figure 21. Global Top Biosimilar of Remicade Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar of Remicade as of 2022)
• Figure 22. The Top 10 and 5 Players Market Share by Biosimilar of Remicade Revenue in 2022
• Figure 23. North America Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 24. North America Biosimilar of Remicade Market Share by Type (2018-2029)
• Figure 25. North America Biosimilar of Remicade Market Share by Application (2018-2029)
• Figure 26. North America Biosimilar of Remicade Market Share by Country (2018-2029)
• Figure 27. United States Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 28. Canada Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 29. Europe Biosimilar of Remicade Market Size YoY (2018-2029) & (US$ Million)
• Figure 30. Europe Biosimilar of Remicade Market Share by Type (2018-2029)
• Figure 31. Europe Biosimilar of Remicade Market Share by Application (2018-2029)
• Figure 32. Europe Biosimilar of Remicade Market Share by Country (2018-2029)
• Figure 33. Germany Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 34. France Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 35. U.K. Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 36. Italy Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 37. Russia Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 38. Nordic Countries Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 39. China Biosimilar of Remicade Market Size YoY (2018-2029) & (US$ Million)
• Figure 40. China Biosimilar of Remicade Market Share by Type (2018-2029)
• Figure 41. China Biosimilar of Remicade Market Share by Application (2018-2029)
• Figure 42. Asia Biosimilar of Remicade Market Size YoY (2018-2029) & (US$ Million)
• Figure 43. Asia Biosimilar of Remicade Market Share by Type (2018-2029)
• Figure 44. Asia Biosimilar of Remicade Market Share by Application (2018-2029)
• Figure 45. Asia Biosimilar of Remicade Market Share by Region (2018-2029)
• Figure 46. Japan Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 47. South Korea Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 48. China Taiwan Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 49. Southeast Asia Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 50. India Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 51. Australia Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 52. Middle East, Africa, and Latin America Biosimilar of Remicade Market Size YoY (2018-2029) & (US$ Million)
• Figure 53. Middle East, Africa, and Latin America Biosimilar of Remicade Market Share by Type (2018-2029)
• Figure 54. Middle East, Africa, and Latin America Biosimilar of Remicade Market Share by Application (2018-2029)
• Figure 55. Middle East, Africa, and Latin America Biosimilar of Remicade Market Share by Country (2018-2029)
• Figure 56. Brazil Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 57. Mexico Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 58. Turkey Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 59. Saudi Arabia Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 60. Israel Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 61. GCC Countries Biosimilar of Remicade Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 62. Roche Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 63. Amgen Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 64. AbbVie Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 65. Sanofi-Aventis Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 66. Johnson & Johnson Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 67. Pfizer Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 68. Novo Nordisk Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 69. Eli Lilly Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 70. Novartis Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 71. Merck Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 72. 3sbio Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 73. Changchun High Tech Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 74. CP Guojian Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 75. Biotech Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 76. Gelgen Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 77. Innovent Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 78. Dong Bao Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 79. Ganlee Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 80. United Laboratories Revenue Growth Rate in Biosimilar of Remicade Business (2018-2023)
• Figure 81. Bottom-up and Top-down Approaches for This Report
• Figure 82. Data Triangulation
• Figure 83. Key Executives Interviewed